Clinical and Renal Histology Findings and Different Responses to Induction Treatment Affecting the Long-Term Renal Outcomes of Children With ANCA-Associated Vasculitis: a Single-Center Cohort Analysis

被引:8
作者
Yang, Jing [1 ]
Yang, Yuan [1 ]
Xu, Yongli [1 ]
Zhou, Lanqi [1 ]
Zhou, Luowen [2 ]
Yin, Xiaoling [1 ]
Pu, Jinyun [1 ]
Yang, Fengjie [1 ]
Liu, Yaping [1 ]
He, Yonghua [1 ]
Chen, Yaxian [1 ]
Yuan, Huiqing [1 ]
Qiu, Liru [1 ]
Zhang, Yu [1 ]
Chen, Yu [1 ]
Liu, Tonglin [1 ]
Tang, Jinhui [1 ]
Zhou, Jianhua [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
ANCA-associated vasculitis; children; remission-induction treatment; ESRD; progression; renal survival; HISTOPATHOLOGIC CLASSIFICATION; GLOMERULONEPHRITIS; DETERMINANTS;
D O I
10.3389/fimmu.2022.857813
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IntroductionAntineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is relatively rare in children. This article aimed to analyze clinical and renal histology findings and different responses to induction treatment associated with the long-term renal outcomes in children with AAV in a single center. MethodsAll pediatric patients with AAV admitted to Tongji Hospital from January 2002 to January 2021 were included in the study. The demographic, clinical, pathological, laboratory, and treatment data and outcomes were collected and analyzed to identify predictors associated with response to induction treatment and progression to end-stage renal disease (ESRD). ResultsIn total, 48 children with AAV were included in this cohort; 81.25% of them were women, and 91.7% were microscopic polyangiitis (MPA). Kidney involvement was found in 45 patients (93.75%). The most common histopathological subtype was crescentic form in this cohort according to Berden's classification. In total, 34 patients (70.8%) showed eGFR <60 ml/min/1.73 m(2) at the time of diagnosis. Complete and partial remission was achieved in 8 patients (16.7%) and 19 patients (39.6%), respectively, following 6-month induction treatment. Half of the patients eventually progressed to ESRD at a mean time of (13.04 +/- 15.83) months after diagnosis. The independent predictors of nonremission following induction treatment and progression to ESRD were baseline eGFR ConclusionsOur study demonstrates that women, MPA, and crescentic subtypes are predominant in pediatric AAV in China. Initial renal failure (eGFR <60 ml/min/1.73 m(2)), hypertension, sclerotic pathological subtype, and nonremission following induction treatment are predictive of long-term renal outcomes.
引用
收藏
页数:9
相关论文
共 32 条
[11]   Long-term patient survival in ANCA-associated vasculitis [J].
Flossmann, Oliver ;
Berden, Annelies ;
de Groot, Kirsten ;
Hagen, Chris ;
Harper, Lorraine ;
Heijl, Caroline ;
Hoglund, Peter ;
Jayne, David ;
Luqmani, Raashid ;
Mahr, Alfred ;
Mukhtyar, Chetan ;
Pusey, Charles ;
Rasmussen, Niels ;
Stegeman, Coen ;
Walsh, Michael ;
Westman, Kerstin .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (03) :488-494
[12]   Histopathologic and Clinical Predictors of Kidney Outcomes in ANCA-Associated Vasculitis [J].
Ford, Sharon L. ;
Polkinghorne, Kevan R. ;
Longano, Anthony ;
Dowling, John ;
Dayan, Sukhpal ;
Kerr, Peter G. ;
Holdsworth, Stephen R. ;
Kitching, A. Richard ;
Summers, Shaun A. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (02) :227-235
[13]   Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK [J].
Fujimoto, Shouichi ;
Watts, Richard A. ;
Kobayashi, Shigeto ;
Suzuki, Kazuo ;
Jayne, David R. W. ;
Scott, David G. I. ;
Hashimoto, Hiroshi ;
Nunoi, Hiroyuki .
RHEUMATOLOGY, 2011, 50 (10) :1916-1920
[14]   ANCA-Associated Vasculitis: Core Curriculum 2020 [J].
Geetha, Duvuru ;
Jefferson, J. Ashley .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (01) :124-137
[15]   Determinants of outcome in ANCA-associated glomerulonephritis:: A prospective clinico-histopathological analysis of 96 patients [J].
Hauer, HA ;
Bajema, IM ;
Van Houwelingen, HC ;
Ferrario, F ;
Noël, LH ;
Waldherr, R ;
Jayne, DRW ;
Rasmussen, N ;
Bruijn, JA ;
Hagen, EC .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1732-1742
[16]   2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides [J].
Jennette, J. C. ;
Falk, R. J. ;
Bacon, P. A. ;
Basu, N. ;
Cid, M. C. ;
Ferrario, F. ;
Flores-Suarez, L. F. ;
Gross, W. L. ;
Guillevin, L. ;
Hagen, E. C. ;
Hoffman, G. S. ;
Jayne, D. R. ;
Kallenberg, C. G. M. ;
Lamprecht, P. ;
Langford, C. A. ;
Luqmani, R. A. ;
Mahr, A. D. ;
Matteson, E. L. ;
Merkel, P. A. ;
Ozen, S. ;
Pusey, C. D. ;
Rasmussen, N. ;
Rees, A. J. ;
Scott, D. G. I. ;
Specks, U. ;
Stone, J. H. ;
Takahashi, K. ;
Watts, R. A. .
ARTHRITIS AND RHEUMATISM, 2013, 65 (01) :1-11
[17]   Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis. [J].
Jones, Rachel B. ;
Tervaert, Jan Willem Cohen ;
Hauser, Thomas ;
Luqmani, Raashid ;
Morgan, Matthew D. ;
Peh, Chen Au ;
Savage, Caroline O. ;
Segelmark, Marten ;
Tesar, Vladimir ;
van Paassen, Pieter ;
Walsh, Dorothy ;
Walsh, Michael ;
Westman, Kerstin ;
Jayne, David R. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) :211-220
[18]   Pauci-immune glomerulonephritis in children: A clinicopathologic study of 21 patients [J].
Khalighi, Mazdak A. ;
Wang, Shihtien ;
Henriksen, Kammi J. ;
Bock, Margret ;
Keswani, Mahima ;
Chang, Anthony ;
Meehan, Shane M. .
PEDIATRIC NEPHROLOGY, 2015, 30 (06) :953-959
[19]   Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis [J].
Kouri, Anne M. ;
Andreoli, Sharon P. .
PEDIATRIC NEPHROLOGY, 2017, 32 (03) :449-455
[20]   Clinical associations of renal involvement in ANCA-associated vasculitis [J].
Kronbichler, Andreas ;
Shin, Jae Il ;
Lee, Keum Hwa ;
Nakagomi, Daiki ;
Quintana, Luis F. ;
Busch, Martin ;
Craven, Anthea ;
Luqmani, Raashid A. ;
Merkel, Peter A. ;
Mayer, Gert ;
Jayne, David R. W. ;
Watts, Richard A. .
AUTOIMMUNITY REVIEWS, 2020, 19 (04)